In the PET trial, RAP-219 achieved and exceeded target receptor occupancy, increasing support for the dosing regimen utilized in the ongoing Phase 2a trial in focal epilepsy; restricted ...

A pain-relieving medication might be safer for seniors than first thought.A new study published Jan. 7 in the Annals ...

In the MAD-2 trial, RAP-219 was observed to be generally well tolerated with faster titration and higher exposures than in the initial MAD trial Data underscore the potential broad therapeutic index ...

ProNerve 6 Is a nerve health supplement designed to support optimal nerve function and overall neurological well-being.

That can create a “potential snowball effect” of bias that further amplifies human behavior, one researcher said in a press release, partly because the authors said people seem to believe AI is more ...

A top NYC weight-loss doctor shared the surprising skin complication that he’s encountered in patients using GLP-1 drugs like ...

Pacira receives FDA approval for a new iovera Smart Tip aimed at expanding pain management capabilities to deeper nerves like ...

These findings counter clinical trial results published in June which found that Paxlovid was safe to take but did not lessen ...

Biohaven Ltd. (NYSE: BHVN) today announced that Vlad Coric, M.D., Chairman and Chief Executive Officer, will present at the 43rd Annual J.P. Morgan Healthcare Conference at The Westin St. Francis ...

Pacira launches a new iovera° Smart Tip for chronic back pain relief, offering an alternative to radiofrequency ablation with ...

BioSciences has received clearance from the U.S. Food & Drug Administration to market a new Smart Tip designed to access the ...

Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives of ...